From the University Department of Neurology, Utrecht, the
Netherlands.
Correspondence to Jeannette W. Hop, MD, University Department of Neurology, PO Box 85500, 3508 GA Utrecht, Netherlands. E-mail j.w.hop{at}neuro.azu.nl
MethodsIn a consecutive series of 64 patients and 51 partners
studied 4 months after the SAH, we assessed functional outcome by means
of the Rankin Scale, and QoL by means of the SF-36, the Sickness Impact
Profile (SIP), and a visual analogue scale. Additionally, we asked two
"simple questions" about dependency and recovery. All
questionnaires were completed in an interview setting. The scores on
the QoL instruments from patients and partners were stratified
according to the Rankin grades of the patients and were compared with
data from a Dutch reference population.
ResultsOnly patients who had no symptoms at all (Rankin grade 0)
had no reduction in QoL compared with the reference population; some of
these patients even indicated an improvement in QoL from before the SAH
according to the visual analogue scale. Patients who had symptoms but
were independent (Rankin grades 1 to 3) and therefore usually
designated as having "good outcome" often had reductions in QoL, on
both the physical and psychosocial subscores of the SIP and SF-36. The
QoL of partners was considerably reduced in several psychosocial
domains.
ConclusionsSAH has a considerable impact on the QoL of patients
and their partners. Only patients without residual symptoms (Rankin
grade 0) have a good outcome in terms of physical performance
and QoL.
In a prospectively collected, consecutive series of patients with
aneurysmal SAH, we studied QoL 4 months after the
hemorrhage. Because the current experience on QoL assessment
after SAH is limited, we applied two validated QoL instruments and a
visual analogue scale. To study the association between functional
outcome and QoL, we compared the QoL assessments with the scores on the
Rankin scale, a functional outcome instrument frequently used in stroke
research. To study the impact of SAH on the partners of patients, we
also assessed the partners' QoL.
Instruments
Additionally, we applied two simple questions that were developed to
measure outcome of stroke in large clinical
trials.27 28 29 One question regarded dependency
("Do you require help from another person for everyday
activities?") and the other recovery ("Do you feel you have made a
complete recovery from your stroke [in this case, SAH]?").
We assessed QoL by means of the SIP, the SF-36, and a visual analogue
scale. The SIP contains 136 items about sickness-related dysfunction in
12 domains of daily life: ambulation, mobility, body care, and movement
(which together can be aggregated into a physical subscore); social
interaction, alertness behavior, emotional behavior, communication
(which can be aggregated into a psychosocial subscore); sleep and rest,
eating, work, recreation and pastimes, and home management (which are
independent categories). The SIP has been validated both in English and
Dutch30 31 32 and is frequently used in clinical
outcome research. Scores can be calculated for the instrument as a
whole, for each category, and for the physical and psychosocial
subdimensions. The SIP is easy to administer because the questions are
in a "yes-no" format, but it is also time consuming (20 to 30
minutes).
The SF-36 is brief (5 to 10 minutes) and can be self-administered. The
SF-36 measures 8 health-related domains: physical functioning (10
items), role limitations because of physical health problems (4 items),
bodily pain (2 items), social functioning (2 items), general mental
health (psychological distress and psychological well-being; 5 items),
role limitations because of emotional problems (3 items), vitality (4
items), and general health perceptions (5 items). A single item is
added to assess any change in health compared with 1 year before. The
validity and reliability of the SF-36 have been studied in several
populations.33 34 35 36 37 The psychometric qualities of
the Dutch version have been tested in a random population
sample.38 We also presented a VAS,
ranging from 0 (poor) to 100 (excellent), with the following questions:
"How did you do before the hemorrhage?" (for partners:
"How did you do before your partner's hemorrhage?") and
"How are you now?" Patients and partners were asked to respond by
putting a mark on the scale, taking into account their integrated
physical, psychological, and social well-being. The difference between
the two marks was calculated.
Data Collection
Data Analyses
The baseline characteristics of the 64 patients in whom follow-up data
were obtained are listed in Table 1
The mean SIP scores of patients with Rankin grade 0 ("no symptoms")
did not differ by more than 0.5 standard deviation from the scores of
the reference population, with the exception of the subcategory
"work" (Fig 1
Fig 2
Fig 3
Fig 5
Table 2
For patients with Rankin grades 1 to 3, who are independent and
therefore often classified as having a good outcome, QoL is
considerably reduced for both physical and psychosocial domains. The
closer correlation for the physical domains and the Rankin grade than
for the psychosocial domains and the Rankin grade indicates that the
Rankin scale mainly reflects physical abilities. This is exemplified at
the often-used cutoff level between patients with Rankin grades 1 to 3
and those with a Rankin grade 4: the most conspicuous difference in QoL
between these two groups is in the physical domains. The low Somers' D
statistic for psychosocial domains in relation to the Rankin grade
suggests that the Rankin scale is insufficient to detect reductions in
QoL in the psychosocial domains.
The simple questions reliably discriminated between Rankin grades 4 and
5 (dependent, not recovered); Rankin grades 3,2, and 1 (independent,
not recovered), and Rankin grade 0 (independent and recovered).
It is difficult to compare our results with previous studies on QoL
after SAH,2 3 10 43 because in these studies QoL
was assessed only with semistructured interviews or self-rating scales
and not with the validated instruments we used. The SIP and the SF-36
have been applied to stroke patients in general but not to the subset
of patients with SAH.12 35 39 44 45 Two findings
support the separate study of outcome in SAH: the mean age is much
lower in SAH patients than in stroke patients in general; and the brain
damage in SAH is more likely to be diffuse or multifocal as a result of
global ischemia (caused by a reduction in cerebral perfusion
shortly after the aneurysmal rupture or during secondary
ischemia or hydrocephalus), whereas the lesions in patients
with intracerebral infarction or hemorrhage are
usually localized.
We found that SAH also has considerable impact on the QoL of partners
of patients, most prominently in the psychosocial domains. This is in
keeping with an increased emotional distress found in spouses or
caregivers of stroke patients in general.46 47 48 49 50
Partners of patients with Rankin grade 0 had even lower QoL scores than
the patients themselves in the domain "role limitations from
emotional problems." This can be explained by the partners' reported
feelings of anxiety and uneasiness. Some partners were afraid to leave
the patient alone, especially if they had witnessed the initial
event.
Because the instruments we used were not designed to measure QoL in
partners of patients, some specific aspects might have remained
undetected. This especially concerns the SIP, which designates only
limitations in daily functioning as reduction in QoL. For example, many
partners had to spend more rather than less time in household
management than before, with possible implications for their overall
QoL. This extra burden in the domain "household management" remains
undetected by the SIP but might eventually result in a lower perceived
health-status, as reflected by lower scores on other subdomains.
Many patients and partners made extra comments about SAH-related
factors that had influenced their QoL. In a positive sense, gratitude
to have survived the hemorrhage and to get a "second
chance" were mentioned by patients and partners. Social relationships
were appreciated more than before. Some patients felt less stressed
than before. In a negative sense, many patients reported a persistent
tiredness, easily provoked anxiety by unspecified sensations in the
head, and general uneasiness. In particular, patients who had amnesia,
with no recollection of the event or the days or weeks that followed,
had difficulty realizing and coping with what had happened. A specific
item that was mentioned four times by patients and partners was fear of
having sex, especially if the hemorrhage had occurred during
sexual intercourse.
Two factors may have caused the QoL scores in our study to be too
favorable. First, we chose not to assess QoL in partners of patients
who had died from their SAH, because this might induce unnecessary
distress. However, a severely reduced QoL is likely in these partners,
and excluding them from our study group might have resulted in a
positive bias. Second, QoL is probably severely reduced for patients
who were not able to comprehend the QoL questionnaire, and exclusion of
these patients also overestimates the QoL for all SAH patients in our
study group.
Our primary aim was to relate the QoL of our study group to the current
outcome assessments of good, fair, and poor. To facilitate the
interpretation of the QoL scores of patients with SAH and their
partners, we included reference data from the Dutch validation studies
of the SIP and the SF-36 in the figures.31 38 In
these studies, SIP and SF-36 scores both were not significantly
different between sexes, but were influenced by age. For the SF-36, we
used the age-adjusted reference data. For the SIP, these data were not
available. The mean age of the population in which the SIP was
validated was 42 years. Because the mean age of our study group is 51
years, the differences from the reference scores may have been slightly
overestimated.
The current outcome categories of good, fair, and poor for patients
after SAH need to be redefined; not only the physical status but also
the psychosocial well-being of patients should be taken into account.
Only patients with Rankin grade 0 really have a good outcome, because
not only their physical condition but also their QoL is satisfying. The
Rankin scale is therefore a valuable and practical instrument to make
this distinction. The cutoff point between fair and poor outcomes could
be set between Rankin grades 3 and 4, although this is based mainly on
the physical abilities of the patient and is not equivalent for all
psychosocial domains of QoL. In large clinical trials, the distinction
between good, fair, and poor outcomes can be made by asking the two
simple questions about dependency and recovery. We recommend that in
future studies attention be paid not only to the proportion of patients
who are independent but also to the proportion of patients with no
symptoms at all.
Received September 3, 1997;
revision received January 19, 1998;
accepted January 20, 1998.
2.
Säveland H, Sonesson B, Brandt L, Uski T,
Zygmunt S, Hindtfelt B. Outcome evaluation following
subarachnoid hemorrhage. J Neurosurg. 1986;64:191196.[Medline]
[Order article via Infotrieve]
3.
Ljunggren B, Sonesson B, Säveland H, Brandt L.
Cognitive impairment and adjustment in patients without neurological
deficits after aneurysmal SAH and early operation. J
Neurosurg. 1985;62:673679.[Medline]
[Order article via Infotrieve]
4.
Sonesson B, Ljunggren B, Säveland H, Brandt L.
Cognition and adjustment after late and early operation for ruptured
aneurysm. Neurosurgery. 1987;21:279287.[Medline]
[Order article via Infotrieve]
5.
McKenna P, Willison JR, Phil B, Lowe D, Neil-Dwyer G.
Cognitive outcome and quality of life one year after
subarachnoid hemorrhage. Neurosurgery. 1989;24:361367.[Medline]
[Order article via Infotrieve]
6.
McKenna P, Willison JR, Lowe D, Neil-Dwyer G. Recovery
after subarachnoid haemorrhage. BMJ. 1989;299:485487.
7.
Tidswell P, Dias PS, Sagar HJ, Mayes AR, Battersby
RDE. Cognitive outcome after aneurysm rupture: relationship to
aneurysm site and perioperative complications.
Neurology. 1995;45:875882.[Abstract]
8.
Vikki J, Holst P, Öhman J, Servo A, Heiskanen O.
Social outcome related to cognitive performance and computed
tomographic findings after surgery for a ruptured intracranial
aneurysm. Neurosurgery. 1990;26:579585.[Medline]
[Order article via Infotrieve]
9.
Hutter BO, Gilsbach JM. Which neuropsychological
deficits are hidden behind a good outcome (Glasgow=1) after
aneurysmal subarachnoid hemorrhage.
Neurosurgery. 1993;33:9991005.[Medline]
[Order article via Infotrieve]
10.
Hutter BO, Gilsbach JM, Kreitschmann I. Quality of life
and cognitive deficits after subarachnoid haemorrhage.
Br J Neurosurg. 1995;9:465475.[Medline]
[Order article via Infotrieve]
11.
Testa MA, Simonson DC. Assessment of quality of life
outcomes. N Engl J Med. 1996;334:835840.
12.
de Haan RJ, Aaronson NK, Limburg M, Langton Hewer R,
van Crevel H. Measuring quality of life in stroke. Stroke. 1993;24:320327.
13.
Vermeulen M, van Gijn J. The diagnosis of
subarachnoid haemorrhage. J Neurol Neurosurg
Psychiatry. 1990;52:826828.
14.
Rinkel GJE, Wijdicks EFM, Vermeulen M, Ramos LMP,
Tanghe HLJ, Hasan D, Meiners LC, van Gijn J.
Nonaneurysmal perimesencephalic subarachnoid
hemorrhage: CT and MR patterns that differ from
aneurysmal rupture. AJNR Am J Neuroradiol. 1991;12:829834.[Abstract]
15.
Drake CG. Report of World Federation on Neurological
Surgeons committee on a universal subarachnoid
hemorrhage grading scale. J Neurosurg. 1988;68:985986.[Medline]
[Order article via Infotrieve]
16.
Testa MA, Nackley JF. Methods for quality of life
studies. Annu Rev Public Health. 1994;15:535559.[Medline]
[Order article via Infotrieve]
17.
Fitzpatrick R, Fletcher A, Gore S, Jones D,
Spiegelhalter D, Cox D. Quality of life measures in health care, I:
applications and issues in assessment. BMJ. 1992;305:10741077.
18.
König-Zahn C, Furer JW, Tax B. Het meten
van de gezondheidstoestand. 1. Algemene gezondheid. Assen,
Netherlands: Van Gorcum; 1993.
19.
Essink-Bot ML, Bonsel GJ. Naar standaardisatie van het
instrumentarium voor het meten van de gezondheidstoestand.
Huisarts en Wetenschap. 1995;38:117121.
20.
Fletcher A, Gore S, Jones D, Fitzpatrick R,
Spiegelhalter D, Cox D. Quality of life measures in health care, II:
design, analysis and interpretation. BMJ. 1992;305:11451148.
21.
König-Zahn C, Furer JW. De keuze van een
vragenlijst. Methodologische en praktische overwegingen. Huisarts
en Wetenschap. 1995;38:110116.
22.
Rankin J. Cerebral vascular accidents in patients
over the age of 60, II: prognosis. Scott Med J. 1957;2:200215.[Medline]
[Order article via Infotrieve]
23.
Bamford JM, Sandercock PAG, Warlow CP, Slattery J.
Interobserver agreement for the assessment of handicap in stroke
patients. Stroke. 1989;20:828. Letter.[Medline]
[Order article via Infotrieve]
24.
Wolfe CDA, Taub NA, Woodrow EJ, Burney PGJ. Assessment
of scales of disability and handicap for stroke patients.
Stroke. 1991;22:12411244.
25.
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA,
van Gijn J. Interobserver agreement for the assessment of handicap
in stroke patients. Stroke. 1988;19:604607.
26.
de Haan R, Limburg M, Bossuyt P, van der Meulen J,
Aaronson N. The clinical meaning of Rankin "handicap" grades after
stroke. Stroke. 1995;26:20272030.
27.
Lindley RI, Waddell F, Livingstone M, Sandercock P,
Dennis MS, Slattery J, Smith B, Warlow C. Can simple questions assess
outcome after stroke? Cerebrovasc Dis. 1994;4:314324.
28.
Dennis M, Wellwood I, Warlow C. Are simple questions a
valid measure of outcome after stroke? Cerebrovasc Dis. 1997;7:2227.
29.
Dennis M, Wellwood I, O'Rourke S, MacHale S, Warlow C.
How reliable are simple questions in assessing outcome after stroke?
Cerebrovasc Dis. 1997;7:1921.
30.
Bergner M, Bobbit RA, Carter WB, Gilson BS. The
Sickness Impact Profile: development and final revision of a health
status measure. Medic Care. 1981;29:787805.
31.
Jacobs HM, Luttik A, Touw-Otten FWMM, de Melker RA. De
"Sickness Impact Profile"; resultaten van een valideringsonderzoek
van de Nederlandse versie. Ned Tijdschr Geneeskd. 1990;134:19501954.[Medline]
[Order article via Infotrieve]
32.
Jacobs HM, Touw-Otten FWMM. De Nederlandse versie van
de Sickness Impact Profile in huisartsgeneeskundig onderzoek.
Huisarts en Wetenschap. 1995;38:122128.
33.
Ware JE, Sherbourne CD. The MOS 36-item Short-Form
Health Survey (SF-36), I: conceptual framework and item selection.
Med Care. 1992;30:473483.[Medline]
[Order article via Infotrieve]
34.
Garrat AM, Ruta DA, Abdalla MI, Buckingham JK, Russell
IT. The SF-36 health survey questionnaire: an outcome measurement
suitable for routine use within the NHS? BMJ. 1993;306:14401444.
35.
Anderson C, Laubscher S, Burns R. Validation of the
Short Form 36 (SF-36) health survey questionnaire among stroke
patients. Stroke. 1996;27:18121816.
36.
McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short
Form Health Survey (SF-36), II: psychometric and clinical tests of
validity in measuring physical and mental health constructs. Med
Care. 1993;31:247263.[Medline]
[Order article via Infotrieve]
37.
McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS
36-item Short Form Health Survey (SF-36), III: tests of data quality,
scaling assumptions, and reliability across diverse patient groups.
Med Care. 1994;32:4066.[Medline]
[Order article via Infotrieve]
38.
van der Zee K, Sanderman R, Heyink J. De
psychometrische kwaliteiten van de MOS-36 Short Form Health Survey
(SF-36) in een Nederlandse populatie. Tijdschr Soc Geneesk. 1993;71:183191.
39.
de Haan RJ, Limburg M, van der Meulen JHP, Jacobs HM,
Aaronson NK. Quality of life after stroke: impact of stroke type and
lesion location. Stroke. 1995;26:402408.
40.
Siegel S, Castellan NJ. Nonparametric
Statistics for the Behaviural Sciences. 2nd ed. New York, NY:
McGraw-Hill Book Co; 1988:303.
41.
Rinkel GJE, Wijdicks EFM, Vermeulen M, Hageman LM, Tans
JTJ, van Gijn J. Outcome in perimesencephalic
(nonaneurysmal) hemorrhage: a follow-up study
in 37 patients. Neurology. 1990;40:11301132.
42.
Brilstra EH, Hop JW, Rinkel GJE. Quality of life after
perimesencephalic haemorrhage. J Neurol Neurosurg
Psychiatry.. 1997;63:382384.
43.
Niemi ML, Laaksonen R, Kotila M, Waltimo O. Quality of
life 4 years after stroke. Stroke. 1988;19:11011107.
44.
Visser MC, Koudstaal PJ, Erdman RAM, Deckers JW,
Passchier J, van Gijn J, Grobbee DE. Measuring quality of life in
patients with myocardial infarction or stroke: a feasibility study of
four questionnaires in the Netherlands. J Epidemiol Community
Health. 1995;49:513517.
45.
King RB. Quality of life after stroke.
Stroke. 1996;27:14671472.
46.
Greveson GC, Gray CS, French JM, James OFW. Long-term
outcome for patients and carers following hospital admission for
stroke. Age Ageing. 1991;20:337344.
47.
Wade DT, Legh-Smith J, Langton-Hewer R. Effects of
living with and looking after survivors of a stroke. BMJ. 1986;293:418420.
48.
Anderson CS, Linto J, Stewart Wynne EG. A
population-based assessment of the impact and burden of caregiving for
long-term stroke survivors. Stroke. 1995;26:843849.
49.
Kinsella GJ, Duffy FD. Psychosocial readjustments in
the spouses of stroke patients. Scand J Rehabil Med. 1979;11:129132.[Medline]
[Order article via Infotrieve]
50.
Kinsella GJ, Duffy FD. Attitudes toward disability
expressed by spouses of stroke patients. Scand J Rehabil
Med. 1980;12:7376.[Medline]
[Order article via Infotrieve]
© 1998 American Heart Association, Inc.
Original Contributions
Quality of Life in Patients and Partners After Aneurysmal Subarachnoid Hemorrhage
![]()
Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Background and PurposeOutcome after
subarachnoid hemorrhage (SAH) is often graded as
"poor," "fair," or "good." Such categories are usually
based on physicians' assessments of physical abilities of patients
rather than on how patients themselves perceive their physical,
psychological, and social well-being. We assessed functional outcome
and quality of life (QoL) in patients with SAH and their
partners.
Key Words: outcome quality of life subarachnoid hemorrhage
![]()
Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
The case-fatality
rate in patients with SAH still approximates 50%, and many studies on
outcome after aneurysmal SAH mainly focus on this high
case-fatality rate.1 In studies that describe
patients who survived the hemorrhage, outcome is often graded
as "poor," "fair," or "good." These categories are
sometimes based on specified outcome measures, such as the Glasgow
Outcome Scale or the Rankin scale, but more often on the presence or
absence of obvious neurological deficits.2 On
scales of that nature, "good outcome" generally means that a
patient has no or only minor focal neurological deficits and is
independent in activities of daily life. However, the absence of
obvious neurological deficits does not necessarily imply that the
patient has made a complete recovery from the hemorrhage.
Studies3 4 5 6 7 8 9 10 that used extensive
neuropsychological testing showed that many patients, even those who
were independent and had no focal deficits, had cognitive impairment
after recovery from SAH. Still, the mere presence or absence of
functional or cognitive deficits does not give insight into the
patients' subjective feelings of physical, psychological, and social
well-being. This comprehensive outcome level is conceptualized as a
person's QoL.11 12
![]()
Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Patients and Partners
We studied a prospectively collected, consecutive series of
patients with SAH from a ruptured aneurysm who were admitted to
the Utrecht University Hospital between September 1995 and
September 1996. The diagnosis of SAH was inferred from the presence of
extravasated blood in the basal cisterns on CT, or if CT was negative,
from xanthochromia of the cerebrospinal fluid.13
Also, in all patients included in our study the aneurysm was
demonstrated by spiral CT angiography, catheter angiography, or both.
Patients with nonaneurysmal perimesencephalic
hemorrhage14 and those with a traumatic,
other nonaneurysmal, or unknown cause of the
subarachnoid hemorrhage were excluded. We assessed the
clinical condition on admission by means of the WFNS scale, a universal
SAH grading scale recommended by the World Federation of Neurological
Surgeons.15 The patient's closest significant
other (a spouse, life-companion, or close family member who had daily
contact with the patient) was eligible as the partner of a patient.
Professional caregivers were not considered a partner for the purpose
of this study.
We chose our instruments on the basis of psychometric qualities
(validity, reliability) and practical aspects (length,
difficulty).16 17 18 19 20 21 To assess functional outcome
we used a modified Rankin scale. The Rankin scale is a 6-point handicap
scale that focuses on restrictions in lifestyle (Table
1).22 23 The Rankin scale,
frequently used in stroke outcome research, is easy to administer,
available in a validated Dutch version, and reliable in terms of
interobserver agreement.24 25 26
View this table:
[in a new window]
Table 1. Patient Characteristics, Categorized by Rankin Grade
of the Patients at Follow-up
We informed the patients and partners about the study shortly
before discharge from hospital and assessed outcome at an outpatient
visit 4 months after the bleed. Patients or partners who were not able
to visit the outpatient clinic for practical or emotional reasons, or
who were otherwise likely to get lost to follow-up, were visited at
home, in a rehabilitation center, or nursing home. We conducted
interviews at home with 6 patient-partner couples and 2 partners of
patients who resided in nursing homes, at a rehabilitation center with
1 patient-partner couple, and at the nursing home where the patients
stayed with 2 partners. All questionnaires were administered in a
face-to-face interview setting and performed by one observer (J.W.H.).
We applied all instruments to the patients; in the partners only the
SF-36, the SIP, and the VAS were applied. Patients and partners were
not separated during the interview, but were requested to answer the
questions individually. After a general introduction, the two simple
questions regarding dependency and recovery were asked. Then we applied
the SF-36, the SIP, and the VAS. Patients and partners were given the
opportunity to add extra items or remarks that were important to their
QoL but which were not mentioned in the questionnaires. At the end of
each interview, the interviewer assessed the Rankin grade of the
patient. If the patient was not able to answer a questionnaire because
of aphasia or severe cognitive deficits (ie, patients with a Rankin
grade of 5), we recorded only the Rankin grade of the patient and
the QoL of the partner. The study was approved by our institutional
review board.
We calculated standard scores for the SF-36 and the SIP by
dividing the differences between the scores of the study group and the
reference population by the standard deviation of the reference
population. These standard scores indicate the number of standard
deviations by which the SF-36 and the SIP scores of the study group
differ from the scores of the reference population. Presented
as line graphs, the standard scores allow comparisons between the study
group and the reference population across the entire profile of the
SF-36 and the SIP.34 39 The relationships between
the QoL scores and the Rankin grades were calculated with the Somers'
D statistic. This is an asymmetrical index of the relationship between
two ordered nonparametric variables, with ranges from
-1 to +1. The extremes reflect a perfect association, whereas the
value 0 indicates an absence of
association.40
![]()
Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Ninety-eight patients with aneurysmal SAH were admitted
during the study period of 1 year. Thirty patients died in the
hospital. Two patients were excluded from our study because they did
not speak Dutch; at 4 months, they had Rankin grades of 1 and 3. Two
patients refused participation at 4 months' follow-up because of
severe emotional lability; both patients had a Rankin grade of 4. The
mean and median time of follow-up was 4 months (SD, 1 month; range, 2.5
to 7 months).
, categorized by Rankin grade at
follow-up. Nine of the 64 patients were not able to fill out the QoL
questionnaire because of severe cognitive deficits. Thus, QoL was
assessed in 55 patients. We assessed QoL in 51 partners, including 8
partners of patients who were not able to fill out the QoL
questionnaire. In 46 instances the partner was a spouse or a cohabitant
and in 5 instances a close relative who had daily contact with the
patient.
). For this reason we
made a distinction between patients with Rankin grade 0 and patients
with other Rankin grades. Fig 1
shows the mean standard SIP scores for
patients with Rankin grade 0, Rankin grades 1 to 3 ("independent"),
Rankin grade 4 ("dependent"), and the reference population. There
was a marked difference in mean SIP scores between patients with Rankin
grades 1 to 3 and patients with Rankin grade 4. This difference was
most prominent for the domains "body care and movement,"
"household management," "ambulation," and the "physical
subscore." Patients with Rankin grades 1 to 3 had relatively worse
scores on the psychosocial subscore of the SIP compared with the
physical subscore. The nonparametric correlation
coefficient, Somers' D statistic for the relationship of the Rankin
score, and the SIP varied from 0.2 to 0.4 for the psychosocial domains
and from 0.3 to 0.6 for the physical domains. For the SIP total,
Somers' D was 0.6; for the physical and psychosocial subscores,
0.4.

View larger version (21K):
[in a new window]
Figure 1. SIP profile of the patients with Rankin grades of
0 to 4. Deviations from reference data are expressed in mean standard
scores. Note: QoL was not assessed in patients with a Rankin grade of
5.
shows the mean standard scores on
the SF-36 for patients with Rankin grades 0, 1 to 3, and 4. Patients
with Rankin grade 0 had even better scores than the reference
population, except for the category "role limitations from physical
problems." There was a marked difference in "physical
functioning" between patients with Rankin grades 1 to 3 and those
with Rankin grade 4. The differences in "role limitations from
emotional problems" were less prominent between these two patient
groups. All patient groups had relatively good scores on "general
health perception." Somers' D varied from 0.2 for "pain" to
0.6 for "role limitations from physical problems."

View larger version (16K):
[in a new window]
Figure 2. SF-36 profile of the patients with Rankin grades
of 0 to 4. Deviations from reference data are expressed in mean
standard scores. Note: QoL was not assessed in patients with a Rankin
grade of 5.
shows the mean standard scores on
the SIP for the partners of patients compared with the Rankin grades of
the patients. The QoL in partners of patients with Rankin grade 0 was
unaffected compared with the reference population, with the exception
of the subcategory "emotional behavior." The reduction in QoL in
partners of patients with Rankin grades 1 to 5 was most prominent for
the categories "emotional behavior," "social interactions,"
"work," and "recreation and pastimes." A similar pattern was
found for the SF-36 (Fig 4
). The QoL of
partners of patients with Rankin grade 0 was worse than in the
reference population only for the domain "role limitations from
emotional problems." Strikingly, this reduction was higher for
partners of patients with Rankin grade 0 than for the patients
themselves. The Somers' D statistic for the SF-36 scores of the
partners varied from 0.00 for "physical functioning" to 0.4 for
"social functioning."

View larger version (19K):
[in a new window]
Figure 3. SIP profile of partners, categorized according to
the Rankin grade of the patients. Deviations from reference data are
expressed in mean standard scores.

View larger version (16K):
[in a new window]
Figure 4. SF-36 profiles of partners, categorized according
to the Rankin grade of the patients. Deviations from reference data are
expressed in mean standard scores.
shows the mean estimated changes in
QoL on the VAS for patients and partners. None of the patients with
Rankin grade 0 reported a reduction in QoL; four patients even reported
an improvement. For all other Rankin grades, QoL decreased in both
patients and partners. Partners of patients with Rankin grade 5 had an
estimated 50% reduction in QoL on the VAS.

View larger version (43K):
[in a new window]
Figure 5. Patients' and partners' mean differences between
overall QoL before and 4 months after the SAH, on a VAS, categorized
according to the Rankin grade of the patients.
shows the distribution of the answers to the
simple questions about dependency and recovery according to the Rankin
grade of the patient. Fifteen of the 19 patients who answered that they
were dependent on others had Rankin grades 4 or 5; 7 of the 10 patients
who regarded themselves as having recovered from the hemorrhage
had Rankin grade 0.
View this table:
[in a new window]
Table 2. Answers to "Simple Questions" About Dependency
and Recovery, Categorized by Rankin Grade of the Patients at
Follow-up
![]()
Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
Our study shows that SAH has a considerable impact on the QoL of
patients who survive the hemorrhage and also on that of their
partners. Only patients with Rankin grade 0 (no symptoms) seem to have
a relatively unaffected QoL. The higher scores on the items "work"
on the SIP and "role limitations from physical problems" on the
SF-36 can be explained by the small proportion of patients that have
returned to their previous jobs at 4 months after the bleed (30%;
always part-time). The majority of patients with a Rankin grade 0
answered "yes" to the question regarding whether they felt they had
made a complete recovery from the bleed. Some patients with Rankin
grade 0 even reported an improvement in QoL on the VAS. This favorable
outcome is also observed in patients with perimesencephalic
hemorrhage, a nonaneurysmal, benign subtype of
SAH with an acute onset of severe headache and almost invariably an
uncomplicated course.14 41 42 A possible
explanation is a changed appreciation of life after the complete
recovery of an acute, life-threatening illness.
![]()
Selected Abbreviations and Acronyms
QoL
=
quality of life
SAH
=
subarachnoid hemorrhage
SF-36
=
Short Form (36-Item) Health Survey
SIP
=
Sickness Impact Profile
VAS
=
visual analogue scale
![]()
Acknowledgments
We thank Dr M.C. Visser for her helpful advice on the design of
this study.
![]()
References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
1.
Hop JW, Rinkel GJE, Algra A, van Gijn J. Case
fatality rates and functional outcome after subarachnoid
hemorrhage: a systematic review. Stroke. 1997;28:660664.
This article has been cited by other articles:
![]() |
C. Vecchione, A. Frati, A. Di Pardo, G. Cifelli, D. Carnevale, M. T. Gentile, R. Carangi, A. Landolfi, P. Carullo, U. Bettarini, et al. Tumor Necrosis Factor-{alpha} Mediates Hemolysis-Induced Vasoconstriction and the Cerebral Vasospasm Evoked by Subarachnoid Hemorrhage Hypertension, July 1, 2009; 54(1): 150 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamashiro, T. Nishi, K. Koga, T. Goto, M. Kaji, D. Muta, J.-i. Kuratsu, and S. Fujioka Improvement of quality of life in patients surgically treated for asymptomatic unruptured intracranial aneurysms J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 497 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. Tseng, P. J. Hutchinson, M. Czosnyka, H. Richards, J. D. Pickard, and P. J. Kirkpatrick Effects of Acute Pravastatin Treatment on Intensity of Rescue Therapy, Length of Inpatient Stay, and 6-Month Outcome in Patients After Aneurysmal Subarachnoid Hemorrhage Stroke, May 1, 2007; 38(5): 1545 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. van den Bergh and on behalf of the MASH Study Group Randomized Controlled Trial of Acetylsalicylic Acid in Aneurysmal Subarachnoid Hemorrhage: The MASH Study Stroke, September 1, 2006; 37(9): 2326 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Blissitt, P. H. Mitchell, D. W. Newell, S. L. Woods, and B. Belza Cerebrovascular Dynamics With Head-of-Bed Elevation in Patients With Mild or Moderate Vasospasm After Aneurysmal Subarachnoid Hemorrhage Am. J. Crit. Care., March 1, 2006; 15(2): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K.C. Wong, R. Boet, W.S. Poon, M. T.V. Chan, W. van den Bergh, G. Rinkel, A. Algra, and On behalf of the MASH Study group Trial Design in "Magnesium Sulphate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial" * Response: Stroke, December 1, 2005; 36(12): 2530 - 2532. [Full Text] [PDF] |
||||
![]() |
W. M. van den Bergh and on behalf of the MASH Study Group Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial Stroke, May 1, 2005; 36(5): 1011 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J.H. Wermer, I.C. van der Schaaf, P. Van Nunen, P.M.M. Bossuyt, C.S. Anderson, and G.J.E. Rinkel Psychosocial Impact of Screening for Intracranial Aneurysms in Relatives With Familial Subarachnoid Hemorrhage Stroke, April 1, 2005; 36(4): 836 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Schuiling, G. J.E. Rinkel, R. Walchenbach, and A. W. de Weerd Disorders of Sleep and Wake in Patients After Subarachnoid Hemorrhage Stroke, March 1, 2005; 36(3): 578 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M A. Visser-Meily, M. W M Post, I. I Riphagen, and E. Lindeman Measures used to assess burden among caregivers of stroke patients: a review Clinical Rehabilitation, June 1, 2004; 18(6): 601 - 623. [Abstract] [PDF] |
||||
![]() |
J. Claassen, S. Peery, K.T. Kreiter, L.J. Hirsch, E.Y. Du, E.S. Connolly, and S.A. Mayer Predictors and clinical impact of epilepsy after subarachnoid hemorrhage Neurology, January 28, 2003; 60(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mayer, K. T. Kreiter, D. Copeland, G. L. Bernardini, J. E. Bates, S. Peery, J. Claassen, Y. E. Du, and E. S. Connolly Jr. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage Neurology, December 10, 2002; 59(11): 1750 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Powell, N Kitchen, J Heslin, and R Greenwood Psychosocial outcomes at three and nine months after good neurological recovery from aneurysmal subarachnoid haemorrhage: predictors and prognosis J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 772 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B M Saciri and N Kos Aneurysmal subarachnoid haemorrhage: outcomes of early rehabilitation after surgical repair of ruptured intracranial aneurysms J. Neurol. Neurosurg. Psychiatry, March 1, 2002; 72(3): 334 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Hamedani, C. K. Wells, L. M. Brass, W. N. Kernan, C. M. Viscoli, J. N. Maraire, I. A. Awad, and R. I. Horwitz A Quality-of-Life Instrument for Young Hemorrhagic Stroke Patients Stroke, March 1, 2001; 32(3): 687 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Gijn and G. J. E. Rinkel Subarachnoid haemorrhage: diagnosis, causes and management Brain, February 1, 2001; 124(2): 249 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rees, C. O'Boyle, and R. MacDonagh Quality of life: impact of chronic illness on the partner J R Soc Med, January 11, 2001; 94(11): 563 - 566. [Full Text] [PDF] |
||||
![]() |
Y. M. Ruigrok, G. J. E. Rinkel, E. Buskens, B. K. Velthuis, and J. van Gijn Perimesencephalic Hemorrhage and CT Angiography : A Decision Analysis Stroke, December 1, 2000; 31(12): 2976 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hackett and C. S. Anderson Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study Neurology, September 12, 2000; 55(5): 658 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W M Raaymakers Functional outcome and quality of life after angiography and operation for unruptured intracranial aneurysms J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 571 - 576. [Abstract] [Full Text] |
||||
![]() |
J. W. Hop, G. J. E. Rinkel, A. Algra, J. W. B. van der Sprenkel, and J. van Gijn Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage Neurology, February 22, 2000; 54(4): 872 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hackett, J. R. Duncan, C. S. Anderson, J. B. Broad, and R. Bonita Health-Related Quality of Life Among Long-Term Survivors of Stroke : Results From the Auckland Stroke Study, 1991-1992 Stroke, February 1, 2000; 31(2): 440 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J Hellawell, R. Taylor, and B. Pentland Persisting symptoms and carers' views of outcome after subarachnoid haemorrhage Clinical Rehabilitation, April 1, 1999; 13(4): 333 - 340. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |